KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Change in Working Capital (2016 - 2025)

Historic Change in Working Capital for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$1.6 billion.

  • Novartis Ag's Change in Working Capital fell 3184000.0% to -$1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.6 billion, marking a year-over-year decrease of 12337.11%. This contributed to the annual value of -$1.6 billion for FY2025, which is 12337.11% down from last year.
  • Novartis Ag's Change in Working Capital amounted to -$1.6 billion in Q4 2025, which was down 3184000.0% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Change in Working Capital registered a high of $1.3 billion during Q3 2025, and its lowest value of -$2.0 billion during Q1 2022.
  • In the last 5 years, Novartis Ag's Change in Working Capital had a median value of $92.5 million in 2021 and averaged -$178.6 million.
  • Per our database at Business Quant, Novartis Ag's Change in Working Capital soared by 123611.11% in 2021 and then crashed by 3184000.0% in 2025.
  • Novartis Ag's Change in Working Capital (Quarter) stood at $1.2 billion in 2021, then tumbled by 61.22% to $456.0 million in 2022, then plummeted by 184.21% to -$384.0 million in 2023, then skyrocketed by 101.3% to $5.0 million in 2024, then plummeted by 31840.0% to -$1.6 billion in 2025.
  • Its last three reported values are -$1.6 billion in Q4 2025, $1.3 billion for Q3 2025, and $442.0 million during Q2 2025.